On July 15th the US Department of Veterans Affairs announced that disability regulations will be changing regarding how the Department of Veterans Affairs views Functional Gastrointestinal Disorders(FGIDs/FGIMDs) such as Irritable Bowel Syndrome.
The new regulations will now list FGIDs as being a “presumed” result of military service during operations within Southeast Asia during the Persian Gulf War that occurred in the early 1990s. This essentially means that a veteran making a disability claim should have an easier task of claiming that their Irritable Bowel Syndrome or Functional Dyspepsia(chronic indigestion) was a result of their service, even if symptoms developed after they had left the military. In the past a veteran had to prove that their symptoms were apparent while they were actively serving during the Gulf War. This made it complicated for many veterans who developed severe gastrointestinal disorders after their tours of duty ended. Continue reading “US Veterans Affairs Disability Regulations More Accepting of IBS” »
Health Canada is strengthening the required side effect warnings on prescriptions of Reglan so that they include more information regarding the likelihood of someone developing debilitating Tardive dyskinesia.
Reglan is the brand name of the drug Metoclopramide which has been used for decades to as an anti-emetic & prokinetic drug. Health Canada is the department which sets health policy within Canada. Health Canada has come out with stronger warnings regarding the major side effect of Tardive dyskinesia. The new warnings will now be required for all prescriptions of Reglan. Continue reading “Reglan Tardive Dyskinesia Side Effect Warnings Boosted In Canada” »
About a month ago I contacted my local congressman, David Wu, asking for his support on “H.R. 2239 – Functional GI and Motility Disorders Research Enhancement Act of 2011“. He recently sent a response back outlining his views on the pending legislation.
Just to recap here is the original letter I sent to David Wu via his website.
I would just like to bring your attention to the house bill HR 2239 “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011”.
I have personally suffered from Irritable Bowel Syndrome for 14 years and went through an acute case of Gastroparesis for 3 months. Both of these diseases have had a profound & lasting affect on my life. Motility related digestive illnesses greatly affect a person’s quality of life & they greatly impact a person’s social, educational & career endeavors. With almost 20% of Americans facing some form of digestive motility disorder, it’s a shame that there isn’t more funding given to researching these diseases.
I ask that you please become a cosponsor of H.R. 2239 by contacting Amy Bos in the office of Congressman James Sensenbrenner, Jr.
Gabriel Hedges Continue reading “David Wu Responds To My H.R. 2239 Inquiry” »
HR 2239 “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011” could increase funding for disease like Gastroparesis or Irritable Bowel Syndrome.
Visit Functional GI and Motility Disorders Research Enhancement Act of 2011 on Facebook.
Everyone out there who is dealing with a functional gastrointestinal and motility disorder(FGIMD) needs to listen up & get the word out to their friends, family & especially their local US district representative about H.R. 2239 the “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011“. The goal of the bill is to increase funding for functional & motility related gastrointestinal diseases. Continue reading “Please Support HR 2239 “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011”” »